Roche Holding AG scrapped long-held global diversity targets for its leadership, showing how pressure from the Trump ...
Meanwhile, fellow Swiss company Novartis will no longer use diverse panels in its hiring process for U.S.-based employees, ...
Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...
An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.
The shareholders approved the total bonuses of the Corporate Executive Committee for the 2024 financial year by 95.00% of votes. They also approved a maximum total future remuneration by 95.15% of ...
The Roche subsidiary Genentech has presented five-year SUNFISH data on Evrysdi (risdiplam) in the final readout of this ...
The Breast Cancer market is undergoing significant expansion, driven by increasing disease prevalence and the introduction of innovative therapeutic options from companies such as ...
Angesichts des Drucks der Trump-Regierung hat der Schweizer Pharmariese Roche seine seit langem bestehenden globalen ...
Roche Holding AG scrapped long-held global diversity targets for its leadership, showing how pressure from the Trump ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback